CY1113640T1 - Μεθοδοι για την θεραπευτικη αγωγη ρευματοειδους αρθριτιδας - Google Patents

Μεθοδοι για την θεραπευτικη αγωγη ρευματοειδους αρθριτιδας

Info

Publication number
CY1113640T1
CY1113640T1 CY20131100102T CY131100102T CY1113640T1 CY 1113640 T1 CY1113640 T1 CY 1113640T1 CY 20131100102 T CY20131100102 T CY 20131100102T CY 131100102 T CY131100102 T CY 131100102T CY 1113640 T1 CY1113640 T1 CY 1113640T1
Authority
CY
Cyprus
Prior art keywords
treatment
methods
rheumatoid arthritis
antibody
fragment
Prior art date
Application number
CY20131100102T
Other languages
English (en)
Inventor
Alan M Solinger
Alexander Owyang
Original Assignee
Xoma Technology Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Technology Ltd. filed Critical Xoma Technology Ltd.
Publication of CY1113640T1 publication Critical patent/CY1113640T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/245—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Abstract

Αποκαλύπτονται συνθέσεις και μέθοδοι για την θεραπευτική αγωγή και/ή αποτροπή ρευματοειδούς αρθρίτιδας, που περιλαμβάνουν χορήγηση σε υποκείμενο αποτελεσματικής ποσότητας αντισώματος αντι-IL-1β ή θραύσματος αυτού.
CY20131100102T 2008-06-06 2013-02-05 Μεθοδοι για την θεραπευτικη αγωγη ρευματοειδους αρθριτιδας CY1113640T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5971108P 2008-06-06 2008-06-06
US9523208P 2008-09-08 2008-09-08
EP09759528A EP2293816B1 (en) 2008-06-06 2009-06-05 Methods for the treatment of rheumatoid arthritis

Publications (1)

Publication Number Publication Date
CY1113640T1 true CY1113640T1 (el) 2016-06-22

Family

ID=40983388

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100102T CY1113640T1 (el) 2008-06-06 2013-02-05 Μεθοδοι για την θεραπευτικη αγωγη ρευματοειδους αρθριτιδας

Country Status (12)

Country Link
US (1) US20110189172A1 (el)
EP (1) EP2293816B1 (el)
JP (2) JP5607613B2 (el)
AU (1) AU2009256072B2 (el)
CA (1) CA2727171A1 (el)
CY (1) CY1113640T1 (el)
DK (1) DK2293816T3 (el)
ES (1) ES2398693T3 (el)
HR (1) HRP20130042T1 (el)
PL (1) PL2293816T3 (el)
PT (1) PT2293816E (el)
WO (1) WO2009149370A1 (el)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8034014B2 (en) 2007-03-06 2011-10-11 Biomet Biologics, Llc Angiogenesis initation and growth
US20080269762A1 (en) * 2007-04-25 2008-10-30 Biomet Manufacturing Corp. Method and device for repair of cartilage defects
EP2391650B1 (en) 2007-12-20 2014-10-15 Xoma (Us) Llc Methods for the treatment of gout
US8753690B2 (en) * 2008-02-27 2014-06-17 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
WO2009108890A1 (en) 2008-02-27 2009-09-03 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
US20110052561A1 (en) * 2009-08-27 2011-03-03 Biomet Biologics,LLC Osteolysis treatment
AU2010292486B2 (en) 2009-08-27 2014-08-07 Biomet Biologics, Llc Implantable device for production of interleukin-1 receptor antagonist
WO2012030593A2 (en) 2010-09-03 2012-03-08 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
CN103328511B (zh) * 2010-09-10 2016-01-20 埃派斯进有限公司 抗-IL-1β抗体及其使用方法
US9011846B2 (en) 2011-05-02 2015-04-21 Biomet Biologics, Llc Thrombin isolated from blood and blood fractions
US9573997B2 (en) * 2012-03-19 2017-02-21 Inserm (Institut National De La Sante Et De La Recherche Medicale) Method for use in the treatment of aneurysm
BR112015009892B1 (pt) 2012-11-05 2022-12-27 Delenex Therapeutics Ag Anticorpo contra il-1 beta, seu método de produção e seu uso, sequência isolada de ácido nucleico, vetor, composição cosmética, de diagnóstico ou farmacêutica, e kit
WO2014095808A1 (en) 2012-12-17 2014-06-26 Delenex Therapeutics Ag Antibodies against il-1 beta
US9758806B2 (en) 2013-03-15 2017-09-12 Biomet Biologics, Llc Acellular compositions for treating inflammatory disorders
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9878011B2 (en) 2013-03-15 2018-01-30 Biomet Biologics, Llc Treatment of inflammatory respiratory disease using biological solutions
WO2015081253A1 (en) 2013-11-26 2015-06-04 Biomet Biologics, Llc Methods of mediating macrophage phenotypes
JP2017537896A (ja) 2014-11-10 2017-12-21 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 二重特異性抗体及び眼科に使用する方法
US10441635B2 (en) 2014-11-10 2019-10-15 Biomet Biologics, Llc Methods of treating pain using protein solutions
CA2963606A1 (en) 2014-11-10 2016-05-19 F.Hoffmann-La Roche Ag Anti-ang2 antibodies and methods of use
US9763800B2 (en) 2015-03-18 2017-09-19 Biomet C. V. Implant configured for hammertoe and small bone fixation
WO2021190553A1 (zh) * 2020-03-27 2021-09-30 中山康方生物医药有限公司 抗IL-1β的抗体、其药物组合物及其用途
CN115281149A (zh) * 2021-05-12 2022-11-04 四川大学华西医院 一种临床前类风湿关节炎(Pre-RA)小鼠模型

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077219A (en) * 1984-05-18 1991-12-31 New England Medical Center Hospitals Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins
EP0569687B1 (en) * 1984-05-18 2002-08-21 New England Medical Center Hospitals, Inc. Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins
US4762914A (en) * 1984-05-18 1988-08-09 Auron Philip E Truncated protein of interleukin-1
US5484887A (en) * 1984-06-19 1996-01-16 Immunex Corporation Homogeneous interleukin 1
US5122459A (en) * 1984-12-31 1992-06-16 Immunex Corporation Gene encoding biologically active human interleukin 1
US4772685A (en) * 1985-10-02 1988-09-20 Merck & Co., Inc. Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies
US4935343A (en) * 1986-08-08 1990-06-19 Syntex (U.S.A.) Inc. Monoclonal antibodies for interleukin-1β
US5474899A (en) * 1987-05-13 1995-12-12 Cistron Biotechnology, Inc. Selective immunoassay for IL-1 β
EP0364778B1 (en) * 1988-10-01 1996-03-13 Otsuka Pharmaceutical Co., Ltd. Antibody against interleukin-1beta
CA2046303C (en) * 1989-02-27 2001-05-01 Lee Gehrke Il-1 biological activity inhibitors
MX9204374A (es) * 1991-07-25 1993-03-01 Idec Pharma Corp Anticuerpo recombinante y metodo para su produccion.
WO1993011236A1 (en) * 1991-12-02 1993-06-10 Medical Research Council Production of anti-self antibodies from antibody segment repertoires and displayed on phage
JP4157160B2 (ja) * 1991-12-13 2008-09-24 ゾーマ テクノロジー リミテッド 改変抗体可変領域の調製のための方法
US5869619A (en) * 1991-12-13 1999-02-09 Xoma Corporation Modified antibody variable domains
WO1994000470A1 (en) * 1992-06-30 1994-01-06 The Wistar Institute Of Anatomy And Biology DEVELOPMENTAL EMBRYONIC MOUSE cDNA LIBRARIES
US5959085A (en) * 1993-11-23 1999-09-28 Schering Corporation Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
US5817476A (en) * 1995-06-07 1998-10-06 Genetics Institute, Inc. Polynucleotides encoding interleukin-1 receptor intracellular ligand proteins
GB0001448D0 (en) * 2000-01-21 2000-03-08 Novartis Ag Organic compounds
AU2001259758A1 (en) * 2000-05-12 2001-11-26 Immunex Corporation Interleukin-1 inhibitors in the treatment of diseases
GB0020685D0 (en) * 2000-08-22 2000-10-11 Novartis Ag Organic compounds
US20030026806A1 (en) * 2000-10-27 2003-02-06 Amgen Inc. Antibodies and other selective IL-1 binding agents that allow binding to IL-1 receptor but not activation thereof
US20030166069A1 (en) * 2000-11-28 2003-09-04 Amgen, Inc. Interleukin-1 receptor antagonist-like molecules and uses thereof
US6727234B2 (en) * 2001-04-03 2004-04-27 University Of Iowa Research Foundation Isoprenoid analog compounds and methods of making and use thereof
EP1423432A4 (en) * 2001-07-26 2006-01-11 Lilly Co Eli ANTIBODIES TO INTERLEUKIN 1 BETA (IL-1BETA)
US20050152850A1 (en) * 2004-01-09 2005-07-14 Engebretson Steven P. Methods and compositions for facilitating metabolic control
US7732478B2 (en) * 2004-01-09 2010-06-08 The Trustees Of Columbia University In The City Of New York Methods for facilitating metabolic control
US8618054B2 (en) * 2004-05-05 2013-12-31 Valorisation-Rechereche Société en Commandite Interleukin-1 receptor antagonists, compositions, and methods of treatment
EP2322552B1 (en) * 2005-06-21 2016-02-10 Xoma (Us) Llc IL-1beta binding antibodies and fragments thereof
KR101749388B1 (ko) * 2005-10-26 2017-06-20 노파르티스 아게 Ｉｌ-1베타 화합물의 신규 용도
CN103405768A (zh) * 2006-12-20 2013-11-27 爱克索马技术有限公司 用于治疗IL-1β相关疾病的方法
EP2391650B1 (en) * 2007-12-20 2014-10-15 Xoma (Us) Llc Methods for the treatment of gout

Also Published As

Publication number Publication date
JP2015007098A (ja) 2015-01-15
ES2398693T3 (es) 2013-03-21
JP5607613B2 (ja) 2014-10-15
PL2293816T3 (pl) 2013-04-30
JP5809338B2 (ja) 2015-11-10
CA2727171A1 (en) 2009-12-10
EP2293816B1 (en) 2012-11-07
US20110189172A1 (en) 2011-08-04
AU2009256072A1 (en) 2009-12-10
PT2293816E (pt) 2013-02-13
JP2011522832A (ja) 2011-08-04
AU2009256072B2 (en) 2015-05-28
HRP20130042T1 (hr) 2013-03-31
EP2293816A1 (en) 2011-03-16
WO2009149370A1 (en) 2009-12-10
DK2293816T3 (da) 2013-02-04

Similar Documents

Publication Publication Date Title
CY1113640T1 (el) Μεθοδοι για την θεραπευτικη αγωγη ρευματοειδους αρθριτιδας
CY1115871T1 (el) Μεθοδοι για την αντιμετωπιση ουρικης αρθριτιδας
CY1123470T1 (el) Αναστολεις ιβατ για την αγωγη ηπατοπαθειων
CY1120102T1 (el) Συνθεσεις και μεθοδοι για μειωση τριγλυκεριδιων χωρις αυξηση επιπεδων ldl-c σε ενα υποκειμενο επι ταυτοχρονης θεραπειας στατινης
CY1124307T1 (el) Φαρμακευτικη συνθεση, μεθοδοι θεραπειας και χρησεις αυτων
CY1122458T1 (el) Αντισωματα αντι-n3pglu αμυλοειδους βητα πεπτιδιου και χρησεις αυτων
CY1122490T1 (el) Αντισωματα κατα του ανθρωπινου cd38
CY1125436T1 (el) Αναστολεις dna-pk
CY1122840T1 (el) Ανθρωποποιημενα ή χιμαιρικα αντισωματα cd3
CY1120181T1 (el) Αντι-cd40 αντισωματα
CY1123552T1 (el) Θεραπειες συνδυασμου με χρηση μοριων προσδεσης psl και pcrv αντι- pseudomonas
CY1118349T1 (el) Παραγοντες συνδεσης me cd19 και χρησεις αυτων
CY1119445T1 (el) Αντισωματα εναντι του ανθρωπινου gdf8
CY1121742T1 (el) Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων
NL301089I2 (nl) imlifidase
CY1121167T1 (el) Βελτιωμενα αντισωματα εναντι της ανθρωπινης φρακταλκινης και χρησεις αυτων
BR112014021498A2 (pt) composto, composição e método para tratar uma doença associada com formação de dna circular covalentemente fechado
CY1119399T1 (el) Aντι-dkk-1 αντισωματα
CR20130624A (es) Proteínas de unión a antígeno
CY1116488T1 (el) Αντισωματα anti-προπερδινης
UA109658C2 (xx) Антитіло проти cgrp
EA201290653A1 (ru) Состав антитела и терапевтические режимы
EA201390933A1 (ru) Антитела против мезотелина и иммуноконъюгаты
CY1117654T1 (el) Πολυαιθυλενογλυκολιωμενη απελινη και χρησεις αυτης
CY1118710T1 (el) Συνθεσεις για την θεραπεια της πολλαπλης σκληρυνσης